2[3]Fagan R, Swindells M. Bioinformatics, target discovery and the pharmaceutical/biotechnology industry[J]. Curr Opin Mol Ther, 2000,2(6):655-661.
3[4]Verma M, Wright G L Jr, Hanash S M, et al. Proteomic approaches within the NCI early detection research network for the discovery and identification of cancer biomarkers[J]. Ann N Y Acad Sci, 2001,945:103-115.
4[5]Steeg E W, Pham H. Application of a novel and fast information-theoretic method to the discovery of higher-order correlations in protein databases[J]. Pac Symp Biocomput, 1998,5(5):573-584.
5[6]Maggio E T, Ramnarayan K. Recent developments in computa-tional proteomics[J]. Trends Biotechnol, 2001,19(7):266-272.
6[7]Chang S K. Biotechnology-updates and new developments[J]. Biomed Environ Sci, 2001,14(1-2):32-39.
7[8]Milburn J. Beyond the genome: turning data into knowledge[J]. Drug Discov Today, 2001,6(17):881-883.
8[9]Karp P D. A strategy for database interoperation[J]. J Comput Biol, 1995,2(4):573-586.
9[10]Reiss T. Drug discovery of the future: the implications of the human genome project[J]. Trends Biotechnol, 2001,19(12):496-499.
10[11]Michelson S, Joho K. Drug discovery, drug development and the emerging world of pharmacogenomics: prospecting for information in a data-rich landscape[J]. Curr Opin Mol Ther, 2000,2(6):651-654.
